サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1643542

外反母趾手術市場：製品別、患者タイプ別、タイプ別、エンドユーザー別、地域別 - 2029年までの予測

Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029
PrevNext
1
2
3
4

出版日
ページ情報
英文 234 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.37円
外反母趾手術市場：製品別、患者タイプ別、タイプ別、エンドユーザー別、地域別 - 2029年までの予測
出版日: 2025年01月22日
発行: MarketsandMarkets
ページ情報: 英文 234 Pages
納期: 即納可能 即納可能とは
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

外反母趾手術の市場規模は、2024年の4億5,840万米ドルから2029年には6億610万米ドルに成長すると予測され、予測期間中の成長率は5.7%になるとみられています。

外反母趾手術件数の増加が外反母趾手術市場の成長を促進する要因です。特に高齢者の間で外反母趾の罹患率が上昇し続けているため、変形を矯正するための外科的治療に対する需要が増加しています。さらに、効果的な治療法に対する認識が高まり、低侵襲手術を含む高度な技術が利用可能になったことで、外反母趾手術の患者数が増加しています。

調査範囲
調査対象年 2022年～2029年
基準年 2023年
予測期間 2024年～2029年
検討単位 金額（100万米ドル）
セグメント 製品別、患者タイプ別、タイプ別、エンドユーザー別、地域別
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ、GCC諸国

エンドユーザー別では、外反母趾手術市場は病院、外来手術センター、整形外科クリニックに区分されます。予測期間中、病院セグメントのCAGRが最も高くなると予測されています。この成長率は、高度な手術技術が利用可能であること、ヘルスケアインフラへの投資が継続的に行われていることに起因しています。病院は拡大し続け、新しく先進的な技術を採用し続けているため、複雑な外反母趾の手術に適した選択肢であり続けています。

「予測期間中、外反母趾手術市場のタイプ別成長率は、低侵襲手術セグメントが最も高くなっています。

タイプ別では、外反母趾手術市場は従来の手術と低侵襲手術に二分されます。低侵襲手術分野は、主に特殊な手術器具などの技術の進歩により、外反母趾手術市場において最も高いCAGRで成長すると予想されています。これらの手術は、外反母趾手術の精度と信頼性を高め、より効果的で利用しやすいものとなっています。

外反母趾手術の世界市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ、GCC諸国に分類されます。特にアジア太平洋は、医療インフラへの投資が増加していることから、外反母趾手術市場において最も高いCAGRを記録しています。これに加えて、急速に高齢化する患者の数は、外反母趾を含む加齢に関連する疾患に対する効果的な治療法を強く求めています。また、アジア太平洋におけるメディカルツーリズム活動の拡大も、先進的な外科治療やハイクラスなヘルスケアサービスを求める患者の急増を考えると、市場に大きな影響を与えています。これらの要因を総合すると、APAC地域は外反母趾手術市場の成長軌道に乗っています。

当レポートでは、世界の外反母趾手術市場について調査し、製品別、患者タイプ別、タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 顧客ビジネスに影響を与える動向/混乱
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • 投資と資金調達のシナリオ
  • 技術分析
  • 特許分析
  • 貿易分析
  • 2025年～2026年の主な会議とイベント
  • 規制状況
  • ポーターのファイブフォース分析
  • 主な利害関係者と購入基準
  • 外反母趾手術市場へのAIの影響

第6章 外反母趾手術市場、製品別

  • イントロダクション
  • インプラントとアクセサリー
  • 修正システム

第7章 外反母趾手術市場、患者タイプ別

  • イントロダクション
  • 成人患者
  • 小児患者

第8章 外反母趾手術市場、タイプ別

  • イントロダクション
  • 従来型手術
  • 低侵襲手術

第9章 外反母趾手術市場、エンドユーザー別

  • イントロダクション
  • 病院
  • 外来手術センター
  • 整形外科クリニック

第10章 外反母趾手術市場、地域別

  • イントロダクション
  • 北米
    • 北米のマクロ経済見通し
    • 米国
    • カナダ
  • 欧州
    • 欧州のマクロ経済見通し
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • アジア太平洋のマクロ経済見通し
    • 中国
    • 日本
    • インド
    • その他
  • ラテンアメリカ
    • ラテンアメリカのマクロ経済見通し
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 医療技術の進歩が市場を牽引
    • 中東・アフリカのマクロ経済見通し
  • GCC諸国
    • 先進的な医療インフラへの注目が高まり市場を牽引
    • GCC諸国のマクロ経済見通し

第11章 競合情勢

  • イントロダクション
  • 主要参入企業の戦略/強み
  • 収益分析、2021年～2023年
  • 市場シェア分析、2023年
  • 企業価値評価と財務指標
  • ブランド/製品比較
  • 企業評価マトリックス：主要参入企業、2023年
  • 企業評価マトリックス：スタートアップ/中小企業、2023年
  • 競合シナリオ

第12章 企業プロファイル

  • 主要参入企業
    • STRYKER
    • ZIMMER BIOMET
    • JOHNSON & JOHNSON SERVICES, INC.
    • SMITH+NEPHEW
    • ENOVIS CORPORATION
    • PARAGON 28, INC.
    • TREACE MEDICAL CONCEPTS, INC.
    • CONMED CORPORATION
    • MEDARTIS AG
    • DOUBLE MEDICAL TECHNOLOGY INC.
    • ARTHREX, INC.
    • ACUMED LLC
    • MERETE GMBH
    • VOOM MEDICAL DEVICES
    • BIOPRO, INC
  • その他の企業
    • DIETER MARQUARDT MEDIZINTECHNIK GMBH
    • EXTREMITY MEDICAL
    • ASTROLABE
    • INVAMED
    • ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES
    • AUXEIN
    • EXACTECH, INC.
    • JEIL MEDICAL CORPORATION
    • AYSAM ORTHOPAEDICS & MEDICAL DEVICES
    • DEVA TIBBI MALZEMELER

第13章 付録

図表

List of Tables

  • TABLE 1 BUNION SURGERY MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 BUNION SURGERY MARKET: RISK ASSESSMENT
  • TABLE 3 FUNDING AND GRANTS IN BUNION SURGERY MARKET, 2021-2022
  • TABLE 4 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS, 2022-2024
  • TABLE 5 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY REGION, 2022-2024
  • TABLE 6 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY KEY PLAYER, 2024 (USD)
  • TABLE 7 BUNION SURGERY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 8 BUNION SURGERY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2023
  • TABLE 9 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 10 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 11 BUNION SURGERY MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICALS AND MEDICAL DEVICES AGENCY
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 BUNION SURGERY MARKET: PORTER'S FIVE FORCES
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
  • TABLE 24 BUYING CRITERIA, BY PRODUCT
  • TABLE 25 BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 26 KEY PRODUCTS IN IMPLANTS & ACCESSORIES MARKET
  • TABLE 27 BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 28 NORTH AMERICA: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 EUROPE: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 LATIN AMERICA: BUNION SURGERY MARKET FOR IMPLANTS & ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 KEY PRODUCTS IN CORRECTION SYSTEMS MARKET
  • TABLE 33 BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 NORTH AMERICA: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 EUROPE: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 LATIN AMERICA: BUNION SURGERY MARKET FOR CORRECTION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 39 BUNION SURGERY MARKET FOR ADULT PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 EUROPE: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: BUNION SURGERY MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 NORTH AMERICA: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 EUROPE: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 LATIN AMERICA: BUNION SURGERY MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 EUROPE: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: BUNION SURGERY MARKET FOR TRADITIONAL SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 NORTH AMERICA: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 EUROPE: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 LATIN AMERICA: BUNION SURGERY MARKET FOR MINIMALLY INVASIVE SURGERIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 61 BUNION SURGERY MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 EUROPE: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: BUNION SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 EUROPE: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 LATIN AMERICA: BUNION SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 72 NORTH AMERICA: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 EUROPE: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 LATIN AMERICA: BUNION SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 BUNION SURGERY MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: BUNION SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: NUMBER OF SURGERIES CONDUCTED, BY COUNTRY, 2022-2029
  • TABLE 83 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 84 US: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 85 US: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 US: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 US: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 88 CANADA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 89 CANADA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 CANADA: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 CANADA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: BUNION SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 94 EUROPE: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 EUROPE: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 97 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 98 GERMANY: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 99 GERMANY: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 GERMANY: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 GERMANY: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 102 UK: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 103 UK: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 UK: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 UK: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 106 FRANCE: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 107 FRANCE: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 FRANCE: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 FRANCE: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 110 ITALY: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 111 ITALY: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 ITALY: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 ITALY: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 114 SPAIN: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 115 SPAIN: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 SPAIN: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 SPAIN: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 118 REST OF EUROPE: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 119 REST OF EUROPE: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 REST OF EUROPE: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 REST OF EUROPE: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: BUNION SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 128 CHINA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 129 CHINA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 CHINA: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 CHINA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 132 JAPAN: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 133 JAPAN: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 JAPAN: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 JAPAN: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 136 INDIA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 137 INDIA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 INDIA: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 INDIA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 140 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: BUNION SURGERY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 150 BRAZIL: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 151 BRAZIL: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 BRAZIL: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 BRAZIL: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 154 MEXICO: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 155 MEXICO: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 MEXICO: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 MEXICO: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 158 REST OF LATIN AMERICA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 159 REST OF LATIN AMERICA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 REST OF LATIN AMERICA: BUNION TYPE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 REST OF LATIN AMERICA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 162 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 167 GCC COUNTRIES: BUNION SURGERY MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: BUNION SURGERY MARKET, BY PATIENT TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 GCC COUNTRIES: BUNION SURGERY MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 GCC COUNTRIES: BUNION SURGERY MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: MACROECONOMIC INDICATORS
  • TABLE 172 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BUNION SURGERY MARKET, 2021-2024
  • TABLE 173 BUNION SURGERY MARKET: DEGREE OF COMPETITION
  • TABLE 174 BUNION SURGERY MARKET: REGION FOOTPRINT
  • TABLE 175 BUNION SURGERY MARKET: PRODUCT FOOTPRINT
  • TABLE 176 BUNION SURGERY MARKET: PATIENT TYPE FOOTPRINT
  • TABLE 177 BUNION SURGERY MARKET: TYPE FOOTPRINT
  • TABLE 178 BUNION SURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 179 BUNION SURGERY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 180 BUNION SURGERY MARKET: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 181 BUNION SURGERY MARKET: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 182 STRYKER: COMPANY OVERVIEW
  • TABLE 183 STRYKER: PRODUCTS OFFERED
  • TABLE 184 STRYKER: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 185 STRYKER: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 186 STRYKER: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 187 STRYKER: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
  • TABLE 188 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 189 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 190 ZIMMER BIOMET: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 191 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW
  • TABLE 192 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED
  • TABLE 193 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 194 JOHNSON & JOHNSON: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 195 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 196 SMITH+NEPHEW: PRODUCTS OFFERED
  • TABLE 197 SMITH+NEPHEW: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 198 ENOVIS CORPORATION: COMPANY OVERVIEW
  • TABLE 199 ENOVIS CORPORATION: PRODUCTS OFFERED
  • TABLE 200 ENOVIS CORPORATION: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 201 ENOVIS CORPORATION: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 202 PARAGON 28, INC.: COMPANY OVERVIEW
  • TABLE 203 PARAGON 28, INC.: PRODUCTS OFFERED
  • TABLE 204 PARAGON 28, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 205 PARAGON 28, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 206 TREACE MEDICAL CONCEPTS, INC.: COMPANY OVERVIEW
  • TABLE 207 TREACE MEDICAL CONCEPTS, INC.: PRODUCTS OFFERED
  • TABLE 208 TREACE MEDICAL CONCEPTS, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 209 TREACE MEDICAL CONCEPTS, INC.: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 210 TREACE MEDICAL CONCEPTS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-NOVEMBER 2024
  • TABLE 211 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 212 CONMED CORPORATION: PRODUCTS OFFERED
  • TABLE 213 MEDARTIS AG: COMPANY OVERVIEW
  • TABLE 214 MEDARTIS AG: PRODUCTS OFFERED
  • TABLE 215 MEDARTIS AG: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 216 MEDARTIS AG: DEALS, JANUARY 2021-NOVEMBER 2024
  • TABLE 217 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW
  • TABLE 218 DOUBLE MEDICAL TECHNOLOGY INC.: PRODUCTS OFFERED
  • TABLE 219 ARTHREX, INC.: COMPANY OVERVIEW
  • TABLE 220 ARTHREX, INC.: PRODUCTS OFFERED
  • TABLE 221 ARTHREX, INC.: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
  • TABLE 222 ACUMED LLC: COMPANY OVERVIEW
  • TABLE 223 ACUMED LLC: PRODUCTS OFFERED
  • TABLE 224 ACUMED LLC: EXPANSIONS, JANUARY 2021-NOVEMBER 2024
  • TABLE 225 MERETE GMBH: COMPANY OVERVIEW
  • TABLE 226 MERETE GMBH: PRODUCTS OFFERED
  • TABLE 227 VOOM MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 228 VOOM MEDICAL DEVICES: PRODUCTS OFFERED
  • TABLE 229 BIOPRO, INC.: COMPANY OVERVIEW
  • TABLE 230 BIOPRO, INC.: PRODUCTS OFFERED
  • TABLE 231 DIETER MARQUARDT MEDIZINTECHNIK GMBH: COMPANY OVERVIEW
  • TABLE 232 EXTREMITY MEDICAL: COMPANY OVERVIEW
  • TABLE 233 ASTROLABE: COMPANY OVERVIEW
  • TABLE 234 INVAMED: COMPANY OVERVIEW
  • TABLE 235 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 236 AUXEIN: COMPANY OVERVIEW
  • TABLE 237 EXACTECH, INC.: COMPANY OVERVIEW
  • TABLE 238 JEIL MEDICAL CORPORATION: COMPANY OVERVIEW
  • TABLE 239 AYSAM ORTHOPAEDICS & MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 240 DEVA TIBBI MALZEMELER: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 BUNION SURGERY MARKETS COVERED AND REGIONAL SCOPE
  • FIGURE 2 BUNION SURGERY MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 7 BUNION SURGERY MARKET: TOP-DOWN APPROACH
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • FIGURE 9 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 BUNION SURGERY MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 INCREASING NUMBER OF BUNION SURGERIES TO DRIVE MARKET
  • FIGURE 15 IMPLANTS & ACCESSORIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 16 ADULT PATIENTS SEGMENT TO DOMINATE MARKET IN 2029
  • FIGURE 17 TRADITIONAL SURGERIES SEGMENT TO HAVE LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 18 HOSPITALS SEGMENT TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 20 BUNION SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 NEW REVENUE POCKETS FOR PLAYERS IN BUNION SURGERY MARKET
  • FIGURE 22 BUNION SURGERY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 23 BUNION SURGERY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 24 BUNION SURGERY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2018-2024
  • FIGURE 26 BUNION SURGERY MARKET: PATENT ANALYSIS, JANUARY 2014-DECEMBER 2024
  • FIGURE 27 BUNION SURGERY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • FIGURE 29 BUYING CRITERIA, BY PRODUCT
  • FIGURE 30 MARKET POTENTIAL OF AI IN BUNION SURGERY MARKET
  • FIGURE 31 NORTH AMERICA: BUNION SURGERY MARKET SNAPSHOT
  • FIGURE 32 ASIA PACIFIC: BUNION SURGERY MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN BUNION SURGERY MARKET, 2021-2023
  • FIGURE 34 BUNION SURGERY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 35 EV/EBITDA OF KEY VENDORS, 2024
  • FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
  • FIGURE 37 BUNION SURGERY MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 38 BUNION SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 BUNION SURGERY MARKET: COMPANY FOOTPRINT
  • FIGURE 40 BUNION SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 STRYKER: COMPANY SNAPSHOT (2023)
  • FIGURE 42 ZIMMER BIOMET: COMPANY SNAPSHOT (2023)
  • FIGURE 43 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ENOVIS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 46 PARAGON 28, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 47 TREACE MEDICAL CONCEPTS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 49 MEDARTIS AG: COMPANY SNAPSHOT (2023)
目次
Product Code: MD 9274

The bunion surgery market is expected to grow by USD 606.1 million in 2029 from USD 458.4 million in 2024 at a growth rate of 5.7% during the forecast period. Increasing numbers of bunion surgeries are the factor driving the growth of the bunion surgery market. With the continued increase in incidence of bunions, especially amongst the elderly population, the demands for surgical treatments to correct deformity increase. Additionally, increasing awareness of effective treatment alternatives and the availability of advanced techniques, including minimally invasive procedures, has increased the number of patients for bunion surgery.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsProduct, Patient Type, Type, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries

"Hospitals segment is expected to have the fastest growth rate in the bunion surgery market, by end user, during the forecast period."

Based on end user, the bunion surgery market is segmented into hospital, ambulatory surgery centers, and orthopedic clinics. The hospital segment is expected to have the highest CAGR during the forecasted period. The growth rate can be attributed to the availability of advance surgical techniques, and ongoing investment in healthcare infrastructure. As hospital continues to expand and adopt new and advance technologies they remain the preferred choice for complex bunion surgery.

"Minimally invasive surgeries segment accounted for the highest growth rate in the bunion surgery market, by type, during the forecast period."

Based on type, the bunion surgery market is bifurcated into traditional surgeries and minimally invasive surgeries. The minimally invasive surgeries segment is expected to grow at the highest CAGR in the market of bunion surgery mainly due to advancement in technological such as specialized surgical tools. These surgeries have enhanced the precision and reliability of bunion surgery, making them more effective and accessible.

"Asia Pacific: The fastest-growing region in bunion surgery market."

The global market for bunion surgery is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. Notably, the Asia-Pacific region marks the highest CAGR in the bunion surgery market, due to increasing investments into healthcare infrastructure. In addition to this, the number of rapidly aging patients strongly demands effective treatments for diseases related to age including bunion. The growing medical tourism activities in the APAC region also happen to be of great influence for the market, given the rapid increase of patients seeking advanced surgical treatments and high-class healthcare services. These factors, collectively, have put the APAC region on a growth trajectory for bunion surgery markets.

The break-up of the profile of primary participants in the bunion surgery market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in the market are Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), CONMED Corporation (US), Zimmer Biomet (US), Treace Medical Concepts, Inc (US), Enovis Corporation (US), Medartis AG (Switzerland), Double Medical Technology Inc. (China), Arthrex, Inc. (US), Acumed LLC (US), Merete GmbH (Germany), BioPro, Inc. (US), Dieter Marquardt Medizintechnik GmbH (Germany), Exactech, Inc. (US), JEIL MEDICAL CORPORATION (South Korea), Ortimplant Orthopaedics & Medical Devices (Turkey), Astrolabe (Portugal), Extremity Medical (US), Voom Medical Devices (US), INVAMED (US), Auxein (India), Aysam Orthopaedics & Medical Devices (Turkey), and Deva TIbbi Malzemeler (Turkey).

Research Coverage:

This research report categorizes the bunion surgery market by product (correction systems and implants & accessories), by patient type (adult patients and pediatric patients), by type (traditional surgeries and minimally invasive surgeries), by end user (hospitals, ambulatory surgery centers, and orthopedic clinics), and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the bunion surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the bunion surgery market. Competitive analysis of upcoming startups in the bunion surgery market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bunion surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing burden of bunion surgery, expanding geriatric population, rising incidence of sports injuries and rheumatoid arthritis, growing demand for minimally invasive surgery, increasing research funding and grants ), opportunities (rising number of hospitals and surgical centers worldwide, growth opportunities in emerging markets), restraints (high cost of surgery), and challenges (availability of non-surgical alternatives) influencing the growth of the bunion surgery market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the bunion surgery market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the bunion surgery market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bunion surgery market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), and Zimmer Biomet (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
    • 2.6.1 PARAMETRIC ASSUMPTIONS
    • 2.6.2 GROWTH RATE ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 BUNION SURGERY MARKET OVERVIEW
  • 4.2 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029
  • 4.3 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029
  • 4.4 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029
  • 4.5 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029
  • 4.6 BUNION SURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing burden of bunion surgeries
      • 5.2.1.2 Expanding geriatric population
      • 5.2.1.3 Rising incidence of sports injuries and rheumatoid arthritis
      • 5.2.1.4 Growing demand for minimally invasive surgeries
      • 5.2.1.5 Increasing research funding and grants
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of surgeries
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising number of hospitals and surgical centers worldwide
      • 5.2.3.2 Growth opportunities in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Availability of non-surgical alternatives
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS
    • 5.4.2 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY REGION
    • 5.4.3 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY KEY PLAYER
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 Implants
    • 5.9.2 COMPLEMENTARY TECHNOLOGIES
      • 5.9.2.1 Correction systems
    • 5.9.3 ADJACENT TECHNOLOGIES
      • 5.9.3.1 Splints
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 IMPORT DATA FOR HS CODE 9021
    • 5.11.2 EXPORT DATA FOR HS CODE 9021
  • 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 REGULATORY ANALYSIS
      • 5.13.1.1 North America
        • 5.13.1.1.1 US
        • 5.13.1.1.2 Canada
      • 5.13.1.2 Europe
      • 5.13.1.3 Asia Pacific
        • 5.13.1.3.1 China
        • 5.13.1.3.2 Japan
        • 5.13.1.3.3 India
      • 5.13.1.4 Latin America
        • 5.13.1.4.1 Brazil
        • 5.13.1.4.2 Mexico
      • 5.13.1.5 Middle East & Africa
    • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT OF NEW ENTRANTS
    • 5.14.2 THREAT OF SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF BUYERS
    • 5.14.4 BARGAINING POWER OF SUPPLIERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA
  • 5.16 IMPACT OF AI ON BUNION SURGERY MARKET
    • 5.16.1 INTRODUCTION
    • 5.16.2 MARKET POTENTIAL OF AI
    • 5.16.3 AI USE CASES
    • 5.16.4 FUTURE OF AI/GEN AI

6 BUNION SURGERY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 IMPLANTS & ACCESSORIES
    • 6.2.1 SHIFTING DEMOGRAPHIC PATTERN TO FACILITATE GROWTH
  • 6.3 CORRECTION SYSTEMS
    • 6.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET

7 BUNION SURGERY MARKET, BY PATIENT TYPE

  • 7.1 INTRODUCTION
  • 7.2 ADULT PATIENTS
    • 7.2.1 CHANGING LIFESTYLE PREFERENCES TO PROMOTE GROWTH
  • 7.3 PEDIATRIC PATIENTS
    • 7.3.1 INCREASING PREVALENCE OF FLAT FEET AND CEREBRAL PALSY TO AID GROWTH

8 BUNION SURGERY MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 TRADITIONAL SURGERIES
    • 8.2.1 RISING POOL OF ARTHRITIS PATIENTS TO EXPEDITE GROWTH
  • 8.3 MINIMALLY INVASIVE SURGERIES
    • 8.3.1 GROWING ADVANCEMENTS IN SPECIALIZED SURGICAL TOOLS TO FUEL MARKET

9 BUNION SURGERY MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 INCREASING DEMAND FOR SPECIALIZED TREATMENTS TO SUSTAIN GROWTH
  • 9.3 AMBULATORY SURGERY CENTERS
    • 9.3.1 RISING INCLINATION TOWARD LOWER COSTS AND SHORTER PATIENT STAYS TO STIMULATE GROWTH
  • 9.4 ORTHOPEDIC CLINICS
    • 9.4.1 GROWING PREFERENCE FOR EFFECTIVE POST-OPERATIVE CARE AND LIMITED HOSPITALIZATION TO BOOST MARKET

10 BUNION SURGERY MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Increasing number of FDA approvals to facilitate growth
    • 10.2.3 CANADA
      • 10.2.3.1 Growing incidence of arthritis to promote growth
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing incidence of osteoporosis to expedite growth
    • 10.3.3 UK
      • 10.3.3.1 Growing demand for surgical treatments to drive market
    • 10.3.4 FRANCE
      • 10.3.4.1 Presence of robust healthcare system to augment growth
    • 10.3.5 ITALY
      • 10.3.5.1 Growing geriatric population to fuel market
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising prevalence of hallux valgus to encourage growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 CHINA
      • 10.4.2.1 Growing public access to modern healthcare to fuel market growth
    • 10.4.3 JAPAN
      • 10.4.3.1 Rise in elderly population to support growth
    • 10.4.4 INDIA
      • 10.4.4.1 High prevalence of arthritis and foot deformities to encourage growth
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing cultural focus on appearance to propel market
    • 10.5.3 MEXICO
      • 10.5.3.1 Increased availability of advanced surgical techniques to augment growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GROWING ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO PROPEL MARKET
    • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.7 GCC COUNTRIES
    • 10.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET
    • 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BUNION SURGERY MARKET
  • 11.3 REVENUE ANALYSIS, 2021-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND/PRODUCT COMPARISON
    • 11.6.1 SMITH+NEPHEW
    • 11.6.2 ZIMMER BIOMET
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Product footprint
      • 11.7.5.4 Patient type footprint
      • 11.7.5.5 Type footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 STRYKER
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product launches
        • 12.1.1.3.2 Deals
        • 12.1.1.3.3 Expansions
        • 12.1.1.3.4 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 ZIMMER BIOMET
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
        • 12.1.2.2.1 Deals
      • 12.1.2.3 MnM view
        • 12.1.2.3.1 Right to win
        • 12.1.2.3.2 Strategic choices
        • 12.1.2.3.3 Weaknesses and competitive threats
    • 12.1.3 JOHNSON & JOHNSON SERVICES, INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
        • 12.1.3.3.2 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 SMITH+NEPHEW
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 ENOVIS CORPORATION
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
        • 12.1.5.3.2 Expansions
    • 12.1.6 PARAGON 28, INC.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches
        • 12.1.6.3.2 Deals
      • 12.1.6.4 MnM view
        • 12.1.6.4.1 Right to win
        • 12.1.6.4.2 Strategic choices
        • 12.1.6.4.3 Weaknesses and competitive threats
    • 12.1.7 TREACE MEDICAL CONCEPTS, INC.
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Product launches
        • 12.1.7.3.2 Deals
        • 12.1.7.3.3 Other developments
    • 12.1.8 CONMED CORPORATION
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 MEDARTIS AG
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Product launches
        • 12.1.9.3.2 Deals
    • 12.1.10 DOUBLE MEDICAL TECHNOLOGY INC.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 ARTHREX, INC.
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Product launches
    • 12.1.12 ACUMED LLC
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Expansions
    • 12.1.13 MERETE GMBH
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 VOOM MEDICAL DEVICES
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 BIOPRO, INC
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 DIETER MARQUARDT MEDIZINTECHNIK GMBH
    • 12.2.2 EXTREMITY MEDICAL
    • 12.2.3 ASTROLABE
    • 12.2.4 INVAMED
    • 12.2.5 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES
    • 12.2.6 AUXEIN
    • 12.2.7 EXACTECH, INC.
    • 12.2.8 JEIL MEDICAL CORPORATION
    • 12.2.9 AYSAM ORTHOPAEDICS & MEDICAL DEVICES
    • 12.2.10 DEVA TIBBI MALZEMELER

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS